| 1. |
- Kragh, Jörgen, et al.
(författare)
-
Optimization of thin asphalt layers : state-of-the-art review
- 2011
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- ERA-NET ROAD initiated a transnational research project titled "Optimization of thin asphalt layers" (OPTHINAL). The DRI-BRRC-VTI Consortium was trusted with carrying out the project and began with a State-of-the-Art report covering, among other things, a literature study and an inventory of experience with using thin asphalt layers (TAL). The results of this phase of the project are given in the present report.This study was limited to thin asphalt mixtures with a maximum thickness of 30 mm, which means that surface dressings or slurry seals were outside the scope of the project. Neither were top layers of double-layer porous pavements considered as TAL, even though such top layers often are 20-30 mm thick. Mix design and optimization was the subject of another study in this project and is therefore not treated here. The main conclusions are that the application of TAL is certainly worthwhile, in particular asa renewable “skin” of a stable road construction having sufficient bearing capacity. The skin serves road users’ need for sufficient skidding resistance and other important functions.
|
|
| 2. |
- Kragh, Jörgen, et al.
(författare)
-
Optimization of thin asphalt layers, OPTHINAL. Final report
- 2011
-
Rapport (övrigt vetenskapligt/konstnärligt)abstract
- ERA-NET ROAD initiated a transnational research project titled "Optimization of thin asphalt layers". Thin asphalt layers have been used extensively and with promising results for more than 15 years in several countries in Europe and abroad. They seem to be cost effective, fast to build and may have good surface properties. In recent years thin asphalt layers have been shown to imply reduced traffic noise levels, increased traffic safety (skid resistance and forward visibility during wet condition) and to be durable compared with traditional alternatives.The DRI-BRRC-VTI Consortium was trusted with carrying out the ERA-NET ROAD project and began with a State-of-the-Art report covering, among other things, a literature study and an inventory of experience with using thin asphalt layers. The results of this phase of the project were documented in a separate project report.The main conclusions were that the application of thin asphalt layers is certainly worthwhile, in particular as a renewable "skin" of a stable road construction having sufficient bearing capacity. The skin serves road users' need for skid resistance and other important functions. Compared with more conventional and traditional surfacing such as dense asphalt concrete 0/11 or stone mastic asphalt 0/11, thin asphalt layers in general come out somewhat better in most respects; for example concerning cost, use of nature resources, rolling resistance, and traffic noise emission. However, there are also drawbacks or problems under special traffic that need to be handled, for example TAL durability when exposed to wear from studded tyres. The availability of premium quality aggregate is a prerequisite for applying thin asphalt layers, and good quality aggregate may be difficult to procure.The present report looks at possibilities to optimize the application of thin asphalt layers, including an analysis of the cost of applying thin asphalt layers compared with the cost of applying more conventional solutions. The study has been limited to thin asphalt layers with a maximum thickness of 30 mm.Recommendations are given concerning the best practice in applying thin asphalt layers and suggestions are given for future research needed to fill the gaps in available knowledge.
|
|
| 3. |
- Ask, Maria, et al.
(författare)
-
Proposed Drilling into Postglacial Faults : The Pärvie Fault System
- 2021
-
Ingår i: Glacially-Triggered Faulting. - Cambridge : Cambridge University Press. - 9781108779906 - 9781108490023 ; , s. 151-174
-
Bokkapitel (refereegranskat)abstract
- Postglacial faults in northern Fennoscandia have been investigated through geophysical methods, trenching, and mapping of brittle deformation structures. Very little is known about postglacial faults through direct measurements. A few short, up to 500 m deep, boreholes exist. Plans for a scientific drilling program were initiated in 2010. The drilling target has been identified: The Pärvie Fault system is the longest known postglacial fault in the world and has been proposed to have hosted an M8 earthquake near the end or just after the last glaciation. Further, this fault system is still microseismically active. The drill sites are north of the Arctic Circle, in a sparsely populated area. Existing site survey data, established logistics, and societal relevance through the fault’s proximity to mining and energy operations make this fault system an appropriate target. The International Continental Scientific Drilling Program approved a full drilling proposal in October 2019. This chapter presents an abbreviated version of the approved proposal.
|
|
| 4. |
|
|
| 5. |
- Damber, Jan-Erik, 1949, et al.
(författare)
-
The Effect of Baseline Testosterone on the Efficacy of Degarelix and Leuprolide: Further Insights From A 12-Month, Comparative, Phase III Study in Prostate Cancer Patients
- 2012
-
Ingår i: Urology. - : Elsevier BV. - 0090-4295 .- 1527-9995. ; 80:1, s. 174-180
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE To investigate the effects of baseline testosterone on testosterone control and prostate-specific antigen (PSA) suppression using data from a phase III trial (CS21) comparing degarelix and leuprolide in prostate cancer. METHODS In CS21, patients with histologically confirmed prostate cancer (all stages) were randomized to degarelix 240 mg for 1 month followed by monthly maintenance doses of 80 or 160 mg, or leuprolide 7.5 mg/month. Patients receiving leuprolide could receive antiandrogens for flare protection. Treatment effects on testosterone and PSA reduction, testosterone surge, and microsurges were investigated in 3 baseline testosterone subgroups: <3.5, 3.5-5.0, and >5.0 ng/mL. Data are presented for the groups receiving degarelix 240/80 mg (the approved dose) and leuprolide 7.5 mg. RESULTS Higher baseline testosterone delayed castration with both treatments. However, castrate testosterone levels and PSA suppression occurred more rapidly with degarelix irrespective of baseline testosterone. With leuprolide, the magnitude of testosterone surge and microsurges increased with increasing baseline testosterone. There was no overall correlation between baseline testosterone and initial PSA decrease in either treatment group, although PSA suppression tended to be slowest with leuprolide and fastest with degarelix in the high baseline testosterone subgroup. CONCLUSION Patients with high baseline testosterone may have greater risk of tumor stimulation (clinical flare) and mini-flares during gonadotrophin-releasing hormone agonist treatment and so the need for flare protection with antiandrogens in these patients is obvious, especially in metastatic disease. Although higher baseline testosterone delays castration, castrate testosterone and PSA suppression occur more rapidly with degarelix, irrespective of baseline testosterone, without the need for flare protection. UROLOGY 80: 174-181, 2012. (c) 2012 Elsevier Inc.
|
|
| 6. |
|
|
| 7. |
- Ghouse, Jonas, et al.
(författare)
-
Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors
- 2021
-
Ingår i: Journal of the American College of Cardiology. - : Elsevier. - 0735-1097 .- 1558-3597. ; 78:7, s. 696-709
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND Angioedema is a rare but potentially life-threatening adverse reaction associated with angiotensinconverting enzyme (ACE) inhibitors. Identification of potential genetic factors related to this adverse event may help identify at-risk patients. OBJECTIVES The aim of this study was to identify genetic factors associated with ACE inhibitor-associated angioedema. METHODS A genomewide association study involving patients of European descent, all taking ACE inhibitors, was conducted in a discovery cohort (Copenhagen Hospital Biobank), and associations were confirmed in a replication cohort (Swedegene). Cases were defined as subjects with angioedema events and filled prescriptions for ACE inhibitors #180 days before the events. Control subjects were defined as those with continuous treatment with ACE inhibitors without any history of angioedema. Odds ratios (ORs) and 95% confidence intervals (CIs) were computed for angioedema risk using logistic mixed model regression analysis. Summary statistics from the discovery and replication cohorts were analyzed using a fixed-effects meta-analysis model. RESULTS The discovery cohort consisted of 462 cases and 53,391 ACE inhibitor-treated control subjects. The replication cohort consisted of 142 cases and 1,345 ACE inhibitor-treated control subjects. In the discovery cohort, 1 locus, residing at chromosome 14q32.2, was identified that associated with angioedema at the genomewide significance level of P <5 x 10-8. The lead variant at this locus, rs34485356, is an intergenic variant located 60 kb upstream of BDKRB2 (OR: 1.62; 95% CI: 1.38 to 1.90; P = 4.3 x 10-9). This variant was validated in our replication cohort with a similar direction and effect size (OR: 1.60; 95% CI: 1.13 to 2.25; P = 7.2 x 10-3). We found that carriers of the risk allele had significantly lower systolic (-0.46 mm Hg per T allele; 95% CI:-0.83 to-0.10; P = 0.013) and diastolic (-0.26 mm Hg per T allele; 95% CI:-0.46 to-0.05; P = 0.013) blood pressure. CONCLUSIONS In this genomewide association study involving individuals treated with ACE inhibitors, we found that common variants located in close proximity to the bradykinin receptor B2 gene were associated with increased risk for ACE inhibitor-related angioedema.
|
|
| 8. |
- Juul-Pedersen, T., et al.
(författare)
-
Sedimentation following the spring bloom in Disko Bay, West Greenland, with special emphasis on the role of copepods
- 2006
-
Ingår i: Marine Ecology-Progress Series. - : Inter-Research Science Center. - 0171-8630 .- 1616-1599. ; 314, s. 239-255
-
Tidskriftsartikel (refereegranskat)abstract
- The sedimentation of particulate organic material was investigated in Disko Bay, West Greenland, during June 2001. Post spring-bloom conditions were encountered, with seasonally decreasing phytoplankton biomass associated with the pycnocline. Calanus finmarchicus, C. glacialis, and C. hyperboreus dominated the zooplankton community, comprising up to 88% of the copepod biomass. Faecal pellet production by C. finmarchicus and C. glacialis was positively correlated to the available food (chlorophyll a > 10 mu m). Results from short-term sediment trap deployments (6 h) showed that particulate organic carbon (POC) sedimentation from the euphotic zone was, on average, 628 mg C m(-2) d(-1), with copepod faecal pellets contributing, on average, 29% of this amount. The faecal pellet contribution to the vertical sinking export of POC was equivalent to that of phytoplankton and amorphous detritus. Yet, on average, 35% of the copepod faecal pellet production was retained within the euphotic zone. The POC: PON (particulate organic nitrogen) ratio of the suspended material in the euphotic zone (8.1 +/- 0.4) was comparable to that of the material collected in the sediment traps just below the euphotic zone (8.0 +/- 0.9). In addition, the daily loss rates of POC and PON within each sampling depth were similar, and the carbon to nitrogen ratio in the sediment traps did not change with depth. These results indicate that the pelagic system had a low retention efficiency of nitrogen just after the spring bloom.
|
|
| 9. |
- Järnerot, G, et al.
(författare)
-
Familial occurrence of microscopic colitis: a report on five families
- 2001
-
Ingår i: Scandinavian Journal of Gastroenterology. - : Informa UK Limited. - 1502-7708 .- 0036-5521. ; 36:9, s. 959-962
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: The etiology and pathogenesis of microscopic colitis is unknown. Whether genetic predisposition is of importance, as in many other gastrointestinal diseases, is unknown. Familial occurrence of collagenous colitis has earlier been reported only in two families. METHODS: Familial occurrence of microscopic colitis was searched for in a Swedish national microscopic colitis register. RESULTS: Familial occurrence of microscopic colitis was identified in five families. In all families a sister-sister relationship was found. Two sisters with collagenous colitis had been living apart in different Nordic countries for many years before developing the disease. In one pair, the smoking sister had collagenous colitis and the never smoking sister had lymphocytic colitis. CONCLUSIONS: Considering the relative rarity of microscopic colitis, these findings indicate that a genetic predisposition may be of importance.
|
|
| 10. |
- Kollberg, Hans, et al.
(författare)
-
Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis : a phase I feasibility study
- 2003
-
Ingår i: Pediatric Pulmonology. - : Wiley. - 8755-6863 .- 1099-0496. ; 35:6, s. 433-40
-
Tidskriftsartikel (refereegranskat)abstract
- Respiratory infection is the major cause of morbidity and mortality in cystic fibrosis (CF) patients. Chronic Pseudomonas aeruginosa (PA) infections ultimately occur in virtually all patients. It is impossible to eradicate PA when a patient has been chronically colonized. Immunotherapy with specific egg-yolk antibodies (IgY) may be an alternative to antibiotics for the prevention of PA infections. We wanted to determine if treatment with specific IgY can prolong the period between the first and the second PA colonization? And long-term, can the treatment diminish the number of positive PA cultures and postpone the onset of chronic colonization? CF patients gargled daily with an IgY-antibody preparation, purified from eggs of hens immunized with PA bacteria. They were compared to a group of patients who did not gargle with the preparation. Both groups had their first colonization with PA eradicated by antibiotics. The basic treatment was essentially the same in both groups. In the initial study, the period between the first and second colonization with PA was significantly prolonged for the treated vs. the control group (Kaplan-Meier P = 0.015, Breslow test). In the prolonged study, the treated group had only 2.5 sputum cultures positive for PA per 100 months of observation, and none of these patients became chronically colonized with PA. No adverse events were reported. In the control group, 13.7 cultures per 100 months of observation were positive for PA, and 5 (24%) patients became chronically colonized with PA. This feasibility study shows that antipseudomonal IgY has the potential to effectively prevent PA colonization without any severe adverse effects. A phase III study should be initiated.
|
|
